GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » 3-Year ROIIC %

Pharma Mar (XMAD:PHM) 3-Year ROIIC % : 3,735.27% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Pharma Mar's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 3,735.27%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Pharma Mar's 3-Year ROIIC % or its related term are showing as below:

XMAD:PHM's 3-Year ROIIC % is ranked better than
98.66% of 1420 companies
in the Biotechnology industry
Industry Median: -14.025 vs XMAD:PHM: 3735.27

Pharma Mar 3-Year ROIIC % Historical Data

The historical data trend for Pharma Mar's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar 3-Year ROIIC % Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.54 1,025.72 656.30 82.85 3,735.27

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 3,735.27 -

Competitive Comparison of Pharma Mar's 3-Year ROIIC %

For the Biotechnology subindustry, Pharma Mar's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's 3-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Pharma Mar's 3-Year ROIIC % falls into.



Pharma Mar 3-Year ROIIC % Calculation

Pharma Mar's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 1.2859524 (Dec. 2023) - 147.2601097 (Dec. 2020) )/( 153.501 (Dec. 2023) - 157.409 (Dec. 2020) )
=-145.9741573/-3.908
=3,735.27%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Pharma Mar  (XMAD:PHM) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Pharma Mar 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Pharma Mar's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (XMAD:PHM) Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (XMAD:PHM) Headlines

From GuruFocus

PulteGroup Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Q2 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2021 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2020 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024